KalVista Pharmaceuticals, Inc. (KALV) revealed Loss for its fourth quarter that increased from last year but beat the Street estimates.
The company's bottom line totaled -$24.11 million, or -$0.98 per share. This compares with -$14.95 million, or -$0.65 per share, in last year's fourth quarter.
Analysts on average had expected the company to earn -$1.09 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
KalVista Pharmaceuticals, Inc. earnings at a glance (GAAP) :
-Earnings (Q4): -$24.11 Mln. vs. -$14.95 Mln. last year.
-EPS (Q4): -$0.98 vs. -$0.65 last year.
-Analyst Estimate: -$1.09
For comments and feedback contact: editorial@rttnews.com